Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Cardiovascular issues in rheumatic diseases

    Cardiovascular disease is a major cause of morbidity and mortality in rheumatic diseases, particularly rheumatoid arthritis and systemic lupus erythematosus. Timely detection and monitoring of cardiovascular a...

    Olena Zimba, Armen Yuri Gasparyan in Clinical Rheumatology (2023)

  2. Article

    Cardiovascular manifestations and comorbidities in rheumatic diseases: perspectives on timely diagnosis, prevention, and treatment

    Armen Yuri Gasparyan in Clinical Rheumatology (2023)

  3. No Access

    Article

    New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome

    The global health crisis caused by the COVID-19 pandemic overwhelmed the capacity of healthcare systems to cope with the rapidly spreading infection and its associated complications. Among these complications,...

    Prakashini MV, Akerke Auanassova, Marlen Yessirkepov, Olena Zimba in Clinical Rheumatology (2023)

  4. Article

    Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic

    Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are characterized by necrotizing inflammation of small and medium-size vessels that often manifest with devastating multi-organ effects....

    Akerke Auanassova, Marlen Yessirkepov, Olena Zimba in Clinical Rheumatology (2023)

  5. Article

    Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses

    Outcomes of COrona VIrus Disease-19 (COVID-19) in patients with rheumatic diseases (RDs) reported in various studies are heterogenous owing to the influence of age and comorbidities which have a significant be...

    Pankti Mehta, Armen Yuri Gasparyan, Olena Zimba, George D. Kitas in Clinical Rheumatology (2022)

  6. Article

    Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management

    Patients with systemic lupus erythematosus (SLE) form a vulnerable group in terms of the impact of the COVID-19 pandemic on disease management. We conducted this overview by searches through Medline/PubMed, Sc...

    Pankti Mehta, Armen Yuri Gasparyan, Olena Zimba, George D. Kitas in Clinical Rheumatology (2022)

  7. Article

    Revisiting reactive arthritis during the COVID-19 pandemic

    Dana Bekaryssova, Marlen Yessirkepov, Olena Zimba in Clinical Rheumatology (2022)

  8. Article

    Reactive arthritis before and after the onset of the COVID-19 pandemic

    Most accepted definitions of reactive arthritis (ReA) consider it a type of spondyloarthritis (SpA) precipitated by a gut or urogenital infection. A wider definition considers any arthritis that occurs after a...

    Dana Bekaryssova, Marlen Yessirkepov, Olena Zimba in Clinical Rheumatology (2022)

  9. No Access

    Article

    Highly cited papers in Takayasu arteritis on Web of Science and Scopus: cross-sectional analysis

    Takayasu arteritis (TAK) is a large vessel vasculitis affecting relatively younger population. Since literature on bibliometric analysis of TAK is scarce, we analyzed top-cited articles in TAK to address this ...

    Durga Prasanna Misra, Vikas Agarwal, Armen Yuri Gasparyan in Clinical Rheumatology (2022)

  10. Article

    Mechanisms of thrombosis in ANCA-associated vasculitis

    Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have a two- to threefold greater risk of develo** venous as well as arterial thrombotic events. Although such thrombotic ...

    Durga Prasanna Misra, Koshy Nithin Thomas, Armen Yuri Gasparyan in Clinical Rheumatology (2021)

  11. Article

    COVID-19 and the clinical course of rheumatic manifestations

    The manifestations of COVID-19 have been evolving over time. Various post-COVID-19 syndromes are being recognised. Various viruses have been implicated in the pathogenesis of autoimmune diseases, and we expect...

    Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan in Clinical Rheumatology (2021)

  12. Article

    Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic

    Comorbidities in rheumatic and musculoskeletal diseases (RMDs) not only increase morbidity and mortality but also confound disease activity, limit drug usage and increase chances of severe infections or drug-a...

    Sakir Ahmed, Armen Yuri Gasparyan, Olena Zimba in Rheumatology International (2021)

  13. No Access

    Article

    Statistical data presentation: a primer for rheumatology researchers

    Statistical presentation of data is key to understanding patterns and drawing inferences about biomedical phenomena. In this article, we provide an overview of basic statistical considerations for data analysi...

    Durga Prasanna Misra, Olena Zimba, Armen Yuri Gasparyan in Rheumatology International (2021)

  14. Article

    Diversifying online rheumatology education options in the era of COVID-19

    Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan in Clinical Rheumatology (2020)

  15. Article

    Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists

    The evolving research landscape in the time of the Coronavirus disease 2019 (COVID-19) pandemic calls for greater understanding of the perceptions of scholars regarding the current state and future of publishi...

    Latika Gupta, Armen Yuri Gasparyan, Olena Zimba in Rheumatology International (2020)

  16. Article

    Moving towards online rheumatology education in the era of COVID-19

    The coronavirus disease-2019 (COVID-19) pandemic has unsettled conventional medical education, hastening a switch to digital platforms and open-access publishing. Rheumatology is a fast evolving academic disci...

    Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan in Clinical Rheumatology (2020)

  17. Article

    Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates

    Repurposing of antirheumatic drugs has garnered global attention. The aim of this article is to overview available evidence on the use of widely used antirheumatic drugs hydroxychloroquine, methotrexate and co...

    Durga Prasanna Misra, Armen Yuri Gasparyan, Olena Zimba in Rheumatology International (2020)

  18. Article

    Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad

    The pathogenesis of Coronavirus disease 2019 (COVID-19) is gradually being comprehended. A high number of thrombotic episodes are reported, along with the mortality benefits of heparin. COVID-19 can be viewed ...

    Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan in Clinical Rheumatology (2020)

  19. Article

    Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets

    The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern. Environmental factors such as air pollution and ...

    Durga Prasanna Misra, Vikas Agarwal, Armen Yuri Gasparyan in Clinical Rheumatology (2020)

  20. Article

    Reflecting on the achievements and looking to the future of an established rheumatology journal

    Armen Yuri Gasparyan in Rheumatology International (2017)

previous disabled Page of 2